Aldeyra Therapeutics's total assets for Q4 2025 were $72.06M, a decrease of -7.38% from the previous quarter. ALDX total liabilities were $27.81M for the fiscal quarter, a -2.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.